This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

15 Oct 2012

GSK adopts new transparency policy

GlaxoSmithKline will allow researchers to access detailed clinical trial data upon request.


GlaxoSmithKline's (GSK) chief executive has announced a new transparency policy that will see the pharmaceutical company share detailed clinical trial data with the wider scientific community.

Related News